A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

May 6, 2020

Study Completion Date

May 6, 2020

Conditions
Depressive Disorder, Major
Interventions
DRUG

JNJ-67953964

JNJ-67953964 10 mg will be administered as two 5-mg capsules orally once daily.

DRUG

Placebo

Matching placebo will be administered as 2 capsules orally once daily.

Trial Locations (53)

2660

Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa), Kyiv

8630

MNCE of Kyiv RC Regional Psychiatric and Narcological Medical Association, Hlevakha

10312

Richmond Behavioural Associates, Staten Island

10629

Emovis GmbH, Berlin

11229

Integrative Clinical Trials LLC, Brooklyn

18104

Lehigh Center for Clinical Research, Allentown

19053

Somni Bene GmbH, Schwerin

20708

CNCE 'Cherkasy Regional Psychiatric Hospital of Cherkasy Regional Council', Smila

25491

Mnpe 'Regional Clinical Psychiatric Hospital of Kirovohrad Regional Council', Nove

28601

Clinical Trials of America, Hickory

29425

Medical University of South Carolina, Charleston

30338

Atlanta Behavioral Research, LLC, Atlanta

32803

APG Research LLC, Orlando

33133

Innova Clinical Trials, Miami

33166

Galiz Research, Miami Springs

33614

Olympian Clinical Research, Tampa

33634

Meridien Research, Tampa

38119

Clinical NeuroScience Solutions Inc, Memphis

43210

Ohio State University, Columbus

45417

Midwest Clinical Research Center, Dayton

60076

Psychiatric Medicine Associates LLC, Skokie

60634

Chicago Research Center, Chicago

61068

Mnpe of Kharkiv Regional Council 'Regional Clinical Psychiatric Hospital #3', Kharkiv

70629

Lake Charles Clinical Trials, Lake Charles

72211

Preferred Research Partners, Little Rock

73106

IPS Research Company, Oklahoma City

73118

Paradigm Research Professionals, LLC, Oklahoma City

73488

CNPE'Kherson Regional Institution of Mental Care'of Kherson Regional Council, Kherson

84088

Advanced Clinical Research, West Jordan

85704

Noble Clinical Research, Tucson

91206

Behavioral Research Specialists LLC, Glendale

91786

Pacific Clinical Research Medical Group, Upland

92078

Artemis Institute for Clinical Research, San Marcos

92503

Artemis Institute for Clinical Research, Riverside

92868

NRC Research Institute, Orange

107076

Clinical Psychiatric Hospital #3 Named After V.A. Gilyarovsky, Moscow

192019

St-Petersburg Bekhterev Psychoneurological Research Institute, Saint Petersburg

199034

City Psychiatric hospital 7 named after I.P.Pavlov, Saint Petersburg

199178

Psychoneurological dispensary 1, Saint Petersburg

344002

Medical and Rehabilitation Research Center Phoenix, Rostov-on-Don

410028

SHI 'Saratov City Clinical Hospital 2 n.a V.I. Razumovsky, Saratov

410060

Saratov Regional Psychiatric hospital named after St. Sofia, Saratov

413124

Engels psychiatric hospital, Saratov Region

634014

Research Institute of Mental Health, Tomsk

08540

Princeton Medical Institute, Princeton

MD2025

ARENSIA, Chisinau

Unknown

Orenburg Regional Clinical Psychiatric Hospital #1, Orenburg

Sverdlovsk Regional Clinical Psychiatric Hospital, Yekaterinburg

S75 3DL

MAC Clinical Research, Barnsley

FY2 0JH

MAC Clinical Research, Blackpool

L34 1BH

MAC Clinical Research, Liverpool

NW10 7EW

Hammersmith Medicines Research Ltd, London

M139NQ

MAC Clinical Research, Manchester

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03559192 - A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression | Biotech Hunter | Biotech Hunter